• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Alimera's Iluvien vision repair implant wins national insurance coverage in France

July 25, 2013 By drugdelivery

pSivida
Alimera Sciences

The French National Health Authority granted Alimera Sciences (NSDQ:ALIM) national insurance coverage for the Iluvien vision repair implant, the company said this week.

Iluvien is a drug/device combo that slowly disperses drugs into the eye over 36 months. Eligible patients with severe chronic disease will be eligible for 100% cost reimbursements under an FNHA federal program.

Alpharetta, Ga.-based Alimera, which licensees Iluvien from pSivida (NSDQ:PSDV), is currently working with the French government on specific pricing and reimbursement rates.

"We believe this opinion will help us in our discussions with the [French Economic Committee of Health Products] pricing committee as we work to make Iluvien available to those suffering from chronic diabetic macular edema in France," said Alimera CEO Dan Myers in prepared remarks.

The product is being sold in the U.K. and Germany and has licenses in 6 countries in Europe, but has had trouble getting onto the market in the U.S.

pSivida launched a Phase III U.S. trial this month, following the FDA’s rejection of Iluvien. The study is the 1st of 2 planned efficacy trials to support the eye implant device.

Filed Under: Drug-Device Combinations Tagged With: Alimera Sciences, Insurance, pSivida Corp.

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS